1. Revision of the Declaration of Helsinki: provoking relevant and important debate

   • Roger Bickerstaffe

   Editorial 24 August 2012 Pages: 113 - 114

2. Building quality measures into the regulatory review process

   • R. N. Smith

   Commentary 24 August 2012 Pages: 115 - 115

3. The bioavailability of glyburide (glibenclamide) under fasting and feeding conditions: a comparative study

   • S. Otoom
   • M. Hasan
   • N. Najib

   Original Article 24 August 2012 Pages: 117 - 120

   

4. Regulation of clinical trials in the European Union: new regime

   • N. Singarayer

   Original Article 24 August 2012 Pages: 121 - 123

5. Comparison of the regulatory controls for medical devices and medicinal products

   • D. B. Jefferys

   Review 24 August 2012 Pages: 125 - 130

6. The revised Declaration of Helsinki: interpreting and implementing ethical principles in biomedical research

   • Analia C. Pérez
   • Robert N. Smith

   Meeting Report 24 August 2012 Pages: 131 - 143

7. EFPIA workshop: the 2001 review of European Union pharmaceutical legislation

   • Donna Ellender
   • Elena Marangoni

   Meeting Report 24 August 2012 Pages: 145 - 149

8. Great expectations meeting: a joint meeting of the Society of Pharmaceutical Medicine and the Association of Research Ethics Committees

   • Society of Pharmaceutical Medicine and the Association of Research Ethics Committees

   Meeting Report 24 August 2012 Pages: 151 - 158

9. Do I want to enrol in a clinical trial? Peter Charlish

   • Elliot Brown

   Book Review 24 August 2012 Pages: 159 - 159

10. Meeting report

    Society of Pharmaceutical Medicine 24 August 2012 Pages: 161 - 161

11. Workplace

    OriginalPaper 24 August 2012 Pages: 163 - 164